Delivery Order SPE2DB25D2204-SPE2DB25FTHBU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,128.44 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by June 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $134,778.88 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,064.22 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, designated as a firm fixed price delivery order, was competitively awarded without a set-aside provision and is scheduled for completion by August 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents under a firm fixed price contract valued at $1,053.01. This non-competitive delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on June 2, 2025, with a ceiling value of $3,159.03 and an ultimate completion date of June 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,846.51 for Varivax vaccine with diluents on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-competitive delivery order with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, leveraging the company's extensive capabilities as a major...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents under a firm fixed price contract. The award was made on July 22, 2025, with an ultimate completion date of August 12, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance. This delivery order represents a child contract—a task order issued under a larger indefinite delivery vehicle—and was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTHBUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,212.04 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without a set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The Varivax vaccine procurement supports military healthcare requirements and aligns with the Defense Health Agency's ongoing pharmaceutical supply needs through the DLA Medical Supply Chain. AmerisourceBergen's extensive portfolio of federal medical contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains. This particular delivery order exemplifies the company's role as a critical vendor for federal vaccine distribution and medical supply chain management supporting U.S. military personnel and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/24/25 |